Amlodipine (as besylate) 5 mg, valsartan 160 mg; tabs. Exforge combines two antihypertensive drugs that have complementary mechanisms of action: amlodipine, a calcium (Ca+) channel blocker, and ...

Novartis has been boosted by data from a new study which shows that its new combination antihypertensive Exforge lowers blood pressure in twice as many patients than those on amlodipine alone.

The full CMI on the next page has more details. If you are worried about using this medicine, speak to your doctor or pharmacist. Exforge HCT contains the active ingredients Amlodipine Besilate, ...

The FDA has approved Novartis‘ Exforge HCT (amlodipine/valsartan/hydrochlorothiazide) tablets, a combination product containing a calcium channel blocker, an ...

Lupin’s Amlodipine and Valsartan tablets are indicated for the treatment of hypertension and to lower blood pressure Lupin announced that its US subsidiary, Lupin Pharmaceuticals Inc. (collectively ...

ZURICH, June 21 (Reuters) - Swiss drugmaker Novartis has received final U.S. approval for its high blood pressure medicine Exforge. Novartis said on Thursday that the U.S. Food and Drug Administration ...

I'm always tired ever since I start treatment of my high BP with no secondary causes this hinders my work life and personal life I am a 20 year old male.How can I stop the side effects. I am currently ...

ZURICH, July 28 (Reuters) - Novartis AG's blood pressure drug Exforge lowers blood pressure in twice as many patients than when they are treated with amlodipine alone, the group said on Monday, citing ...